Abstract
Background Bangladesh is experiencing a rapid increase in non-communicable diseases (NCDs). Early screening is essential to enable timely treatment. In Bangladesh, access to screening services for NCDs is often limited. This study aimed to elicit the willingness to accept (WTA) and the willingness to pay (WTP) for four screening packages for NCDs and their association with the respondents’ sociodemographic characteristics among rural communities in Bangladesh.
Methods A cross-sectional survey using contingent valuation was conducted in six villages of Faridpur district, Bangladesh. The WTP was elicited using a double-bounded dichotomous choice and bidding game approach, with initial bid amounts based on local market prices. Logistic regression was used to identify factors associated with WTA and WTP, and a two-part model was employed to estimate mean WTP and its determinants. We used a double-limit dichotomous choice model with the respondents who took part in the bidding exercise.
Results We found that 83% of the 346 respondents were willing to accept at least one screening package and among these 44% would be willing to pay to accept all screenings. The willingness to accept and pay varied largely by the type of screening being offered, with much lower proportions for obesity than for hypertension and diabetes. The results suggested that individuals from households with a member with an NCD were more willing to accept and pay for screening compared to those from households without an NCD. Married individuals in the highest wealth and expenditure tertiles were also more willing to pay than not-married individuals from middle- and low-wealth and expenditure tertiles. Sex and occupation influenced the amount individuals were willing to pay.
Conclusions Our results encourage the development of screening interventions for NCDs in rural populations. Further research is needed to assess their feasibility, effectiveness and equity in Bangladesh on a larger scale.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We obtained ethical approval for this study, as part of the DClare project, from the University College London Research Ethics Committee (4199/007) and the Ethical Review Committee of the Diabetic Association of Bangladesh (BADAS-ERC/E/19/00276). All respondents gave informed written consent before taking part in the survey.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Anonymised data can be shared upon request from the authors.
